Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 38 Neoplasms 22 Motor Activity 12 Colorectal Neoplasms 9 Lung Neoplasms 8 Stomach Neoplasms 7 Pain, Postoperative 7 Fatigue 7 Anxiety Disorders 6 Pain 5 Carcinoma, Hepatocellular 5 Rectal Neoplasms 4 Polycystic Ovary Syndrome 4 Leukemia, Myeloid, Acute 4 Depression 4 Colonic Neoplasms 4 Thyroid Neoplasms 3 Stomatitis 3 Squamous Cell Carcinoma of Head and Neck 3 Sleep Initiation and Maintenance Disorders 3 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Malnutrition 3 Liver Neoplasms 3 Head and Neck Neoplasms 3 Agnosia 3 Vomiting 2 Uterine Cervical Neoplasms 2 Urinary Incontinence 2

Interventions

pimodivir 1 Sunitinib 1 Rosuvastatin Calcium 1 Olive Oil 1 Midazolam 1 Cyclosporine 1 Control Groups 1 Adalimumab 1 (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Healthy × Control Groups × Clear all

NCT01408459 2025-05-16

DAPH

University of Illinois at Chicago

Phase NA Completed

37 enrolled 9 charts

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡